Morgan Stanley reissued their overweight rating on shares of Cullinan Therapeutics (NASDAQ:CGEM – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a ...

Cullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) shares traded down 2.1% on Friday .The company traded as low as $8.73 and last traded at $8.73. 22,126 shares changed hands during ...

Detailed price information for First Atlantic Nickel Corp (FAN-X) from The Globe and Mail including charting and trades.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Morocco’s central bank, Bank Al-Maghrib (BAM), has introduced a new program to support bank financing for micro-businesses.

Stay updated on market trends for CGEM. MicroStrategy, Portland General Electric And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures were lower this morning ...

Faced with skyrocketing unemployment, the government is banking on a new roadmap for 2025, backed by a budget of 14 billion ...

Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cullinan Therapeutics, Inc. (Nasdaq: CGEM; “Cullinan”), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today reported ...

Bank Al-Maghrib Governor Abdellatif Jouahri announced today in Rabat the launch of a new program aimed at supporting banking ...